Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
Sponsored
BIB
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
55.26
Seasonality Move:
16.48%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.68 | Sell |
20-day SMA: | 60.68 | Sell |
50-day SMA: | 62.63 | Sell |
200-day SMA: | 59.92 | Sell |
8-day EMA: | 56.6 | Sell |
20-day EMA: | 59.52 | Sell |
50-day EMA: | 61.66 | Sell |
200-day EMA: | 60.17 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.32 | Sell |
Relative Strength Index (14 RSI): | 34.01 | Sell |
Chaikin Money Flow: | 7453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.17 - 65.17) | Sell |
Bollinger Bands (100): | (60.25 - 66.99) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 55.10 while BIB 8-day simple moving average is 56.68, which is a Sell signal.
- The stock price of BIB is 55.10 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 60.68, which makes it a Sell.
- ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 62.63 while BIB share price is 55.10, making it a Sell technically.
- BIB stock price is 55.10 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.92, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
32
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a Sell
The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $55.10. The Score for BIB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
55.10
Share Volume:
11.24K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
42.84
Sell
32
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?
The ProShares Ultra Nasdaq Biotechnology stock price is 55.10 USD today. -
Will BIB stock go up or go down?
ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators -
Is ProShares Ultra Nasdaq Biotechnology overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
- ProShares Ultra Nasdaq Biotechnology share price is 55.10 while BIB 8-day exponential moving average is 56.60, which is a Sell signal.
- The stock price of BIB is 55.10 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 59.52, which makes it a Sell.
- ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 61.66 while BIB share price is 55.10, making it a Sell technically.
- BIB stock price is 55.10 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 60.17, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
- BIB Moving Average Covergence Divergence (MACD) indicator is -2.32, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
- ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 34.01, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
- The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (57.17 - 65.17), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
- The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (60.25 - 66.99), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.